Key result
Muscle metaboreflex-induced sympathetically mediated vasoconstriction of ischemic active skeletal muscle is exaggerated in heart failure.
Why the study?
Is muscle metaboreflex-induced vasoconstriction in ischemic active muscle exaggerated in heart failure?
Is muscle metaboreflex-induced vasoconstriction in ischemic active muscle exaggerated in heart failure?
Sympathetically mediated vasoconstriction of ischemic active muscle during muscle metaboreflex activation is exaggerated in heart failure, which may contribute to exercise intolerance in these patients.
May worsen exercise intolerance in HF; leaves open whether metaboreflex modulation improves outcomes.
When oxygen delivery to active muscle is insufficient to meet the metabolic demand during exercise, metabolites accumulate and stimulate skeletal muscle afferents, inducing a reflex increase in blood pressure, termed the muscle metaboreflex. In healthy individuals, muscle metaboreflex activation (MMA) during submaximal exercise increases arterial pressure primarily via an increase in cardiac output (CO), as little peripheral vasoconstriction occurs. This increase in CO partially restores blood flow to ischemic muscle. However, we recently demonstrated that MMA induces sympathetic vasoconstriction in ischemic active muscle, limiting the ability of the metaboreflex to restore blood flow. In heart failure (HF), increases in CO are limited, and metaboreflex-induced pressor responses occur predominantly via peripheral vasoconstriction. In the present study, we tested the hypothesis that vasoconstriction of ischemic active muscle is exaggerated in HF. Changes in hindlimb vascular resistance [femoral arterial pressure ÷ hindlimb blood flow (HLBF)] were observed during MMA (via graded reductions in HLBF) during mild exercise with and without α 1 -adrenergic blockade (prazosin, 50 µg/kg) before and after induction of HF. In normal animals, initial HLBF reductions caused metabolic vasodilation, while reductions below the metaboreflex threshold elicited reflex vasoconstriction, in ischemic active skeletal muscle, which was abolished after α 1 -adrenergic blockade. Metaboreflex-induced vasoconstriction of ischemic active muscle was exaggerated after induction of HF. This heightened vasoconstriction impairs the ability of the metaboreflex to restore blood flow to ischemic muscle in HF and may contribute to the exercise intolerance observed in these patients. We conclude that sympathetically mediated vasoconstriction of ischemic active muscle during MMA is exaggerated in HF. NEW & NOTEWORTHY We found that muscle metaboreflex-induced vasoconstriction of the ischemic active skeletal muscle from which the reflex originates is exaggerated in heart failure. This results in heightened metaboreflex activation, which further amplifies the reflex-induced vasoconstriction of the ischemic active skeletal muscle and contributes to exercise intolerance in patients.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2017) studied Heart failure. Muscle metaboreflex activation with and without alpha-1-adrenergic blockade (prazosin) vs. Normal state (before induction of heart failure) was evaluated on Changes in hindlimb vascular resistance. Muscle metaboreflex-induced sympathetically mediated vasoconstriction of ischemic active skeletal muscle is exaggerated in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: